Important pharmacy news and late-breaking industry information updated daily.
Pharmacists have opportunities to help patients who take DPP-4 inhibitors
Fred's Inc. announced Monday that it has reached a definitive agreement to sell certain assets of its EntrustRx specialty pharmacy unit to a subsidiary of CVS Health. The unit will be sold for $40 million "plus an amount equal to the value of inventory of EntrustRx," Fred's said.
FDA has approved dabrafenib (Tafinlar—Novartis) and trametinib (Mekinist—Novartis), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body, and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).
Here’s everything pharmacists need to know to help patients with sun care needs this season
FDA Commissioner Scott Gottlieb on Thursday signaled that a federal law on kickbacks could be reinterpreted by the government to help lower the prices of prescription drugs. Drug companies are currently being sued by lawyers who assert that the system of rebates that flow between PBMs, drug manufacturers, and insurers are actually kickbacks.
Plaintiffs in five proposed class-action lawsuits filed on May 2 say the opioid epidemic has unfairly increased health insurance costs across the board, not just for those suffering from addiction.
FDA and the Federal Trade Commission (FTC) on Monday issued 13 warning letters to manufacturers, distributors, and retailers for selling e-liquids used in e-cigarettes with labeling and/or advertising that cause them to resemble kid-friendly food products.
CDC: Expect ordering limits and shipping delays through June
The April 1 expansion of Illinois' Medicaid managed-care program to all 102 Illinois counties has accelerated the financial crisis for owners of independent and small-chain pharmacies, according to the Illinois Pharmacists Association. "We've got to fix this," says Garth Reynolds, executive director of the association.
Patients with legitimate needs for pain medication are facing a growing number of obstacles. Patient groups and health providers are increasingly challenging the limits placed on prescription opioids in the name of combating the ongoing epidemic.